Drug Trial Radar · NCT07724132
An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,200
Planned (sponsor's estimate)
Start
Jul 24, 2026
Primary completion
Mar 2031
Study completion Mar 2031
Sponsor
- Lead sponsor
- University College, LondonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute for Health Research, United Kingdom; Imperial College London; UK Dementia Research Institute Ltd; Alzheimers Research UK
- First posted
- Jul 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multicentre, interventional, multi-arm, multi-stage Phase 3 trial including randomisation, double blinding, placebo control evaluation of treatments for sustained clinical response (18 months) in symptomatic Alzheimer's Disease in a population representative of people with Alzheimer's disease in the UK.
Conditions
- Alzheimer's Disease (AD)
- Mild Cognitive Impairment Due to Alzheimer's Disease
- Alzheimer Disease Dementia
Interventions
PlaceboDrug
Oral capsule matching active treatments
AtomoxetineDrug
Atomoxetine (Oral, up to 100 mg/day)
Metformin 1000 mg Oral TabletDrug
Metformin IR Oral, up to 2000 mg/day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) scoreTime frame: Baseline to 18 months
- Change in Amsterdam Instrumental Activities of Daily Living Questionnaire - Short Version (A-IADL-Q-SV) scoreTime frame: Baseline to 18 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Windsor Research Unit
Cambridge, United Kingdom · Recruiting
Two Bridges Research & Development Clinic
Chertsey, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.